[go: up one dir, main page]

NO941593L - Transdermal therapeutic systems with crystallization inhibitors - Google Patents

Transdermal therapeutic systems with crystallization inhibitors

Info

Publication number
NO941593L
NO941593L NO941593A NO941593A NO941593L NO 941593 L NO941593 L NO 941593L NO 941593 A NO941593 A NO 941593A NO 941593 A NO941593 A NO 941593A NO 941593 L NO941593 L NO 941593L
Authority
NO
Norway
Prior art keywords
transdermal therapeutic
therapeutic systems
crystallization inhibitors
crystallization
inhibitors
Prior art date
Application number
NO941593A
Other languages
Norwegian (no)
Other versions
NO941593D0 (en
NO307644B1 (en
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO941593L publication Critical patent/NO941593L/en
Publication of NO941593D0 publication Critical patent/NO941593D0/no
Publication of NO307644B1 publication Critical patent/NO307644B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Described is a transdermal therapeutic system which is characterized in that it includes a crystallization inhibitor, and optionally also penetration enhancers, in an adhesive matrix containing the active substance.
NO941593A 1991-10-31 1994-04-29 Transdermal therapeutic system with crystallization inhibitor NO307644B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (en) 1991-10-31 1992-03-27 TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
PCT/EP1992/002478 WO1993008795A1 (en) 1991-10-31 1992-10-21 Transdermal therapeutic systems containing crystallization inhibitors

Publications (3)

Publication Number Publication Date
NO941593L true NO941593L (en) 1994-04-29
NO941593D0 NO941593D0 (en) 1994-04-29
NO307644B1 NO307644B1 (en) 2000-05-08

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941593A NO307644B1 (en) 1991-10-31 1994-04-29 Transdermal therapeutic system with crystallization inhibitor

Country Status (14)

Country Link
EP (1) EP0610357B1 (en)
JP (1) JP3526864B2 (en)
AT (1) ATE158181T1 (en)
AU (2) AU2895392A (en)
CA (1) CA2120599C (en)
DE (2) DE4210711A1 (en)
DK (1) DK0610357T3 (en)
ES (1) ES2106888T3 (en)
FI (1) FI110061B (en)
GR (1) GR3025237T3 (en)
HU (1) HU227531B1 (en)
NO (1) NO307644B1 (en)
PT (1) PT101019B (en)
WO (1) WO1993008795A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
WO1995001167A2 (en) * 1993-06-25 1995-01-12 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
DE4333595A1 (en) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermal therapeutic system for applying drugs to the skin
DE4405899A1 (en) * 1994-02-18 1995-08-24 Schering Ag Agent for transdermal application containing desogestrel
DE4429667C2 (en) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Compositions for transdermal delivery of acid-labile drugs
DE19500662C2 (en) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Plaster containing estradiol and its use
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
ES2190472T5 (en) † 1995-06-07 2012-03-09 Ortho-Mcneil Pharmaceutical, Inc. TRANSDERMAL PATCH FOR THE ADMINISTRATION OF 17-DEACETIL NORGESTIMATO, IN COMBINATION WITH A STROGEN.
DE19526864A1 (en) * 1995-07-22 1997-01-23 Labtec Gmbh Hormone patches
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (en) * 1996-07-11 1998-01-15 Schering Ag Transdermal therapeutic systems
DE19649535C2 (en) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Process for the production of a plaster-shaped therapeutic system
DE19701949A1 (en) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermal therapeutic system
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (en) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermal patch useful for hormone replacement therapy used for treatment of menopausal symptoms
DE19829713C1 (en) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutic system with the addition of pearlescent pigments
DE19834006A1 (en) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiol-containing patch for the transdermal application of hormones
DE19843027A1 (en) * 1998-09-19 2000-03-23 Labtec Gmbh Transdermal therapeutic system used for administration of sex hormones contains neohesperidin dihydrochalcone to inhibit crystallization of active agent
DK1233763T3 (en) * 1999-11-29 2003-10-20 Lohmann Therapie Syst Lts Transdermal therapeutic systems with improved stability and a method for their preparation
DE10012908B4 (en) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilized supersaturated transdermal therapeutic matrix systems and methods for their preparation
DE10033853A1 (en) * 2000-07-12 2002-01-31 Hexal Ag Transdermal therapeutic system with highly disperse silicon dioxide
IL159415A0 (en) * 2001-06-18 2004-06-01 Noven Pharma Enhanced drug delivery in transdermal systems
PL1670433T3 (en) 2003-10-10 2013-03-29 Ferring Bv Transdermal pharmaceutical formulation for minimizing skin residues
WO2006093139A1 (en) 2005-02-28 2006-09-08 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
WO2009107478A1 (en) 2008-02-27 2009-09-03 久光製薬株式会社 Adhesive skin patch and packaged product
EP2258369B1 (en) 2008-02-27 2015-04-08 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5766475B2 (en) * 2010-03-30 2015-08-19 日東電工株式会社 Patch preparation and method for producing the same
DE102010040299A1 (en) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
US9980920B2 (en) * 2013-09-11 2018-05-29 Medrx Co., Ltd. Base composition for tape agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (en) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts OSTROGEN-ACTIVE PLASTER
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (en) * 1990-04-06 1995-12-13 積水化学工業株式会社 Nitroglycerin patch

Also Published As

Publication number Publication date
DE59208918D1 (en) 1997-10-23
AU1652997A (en) 1997-05-29
NO941593D0 (en) 1994-04-29
FI942011L (en) 1994-04-29
ES2106888T3 (en) 1997-11-16
EP0610357A1 (en) 1994-08-17
FI110061B (en) 2002-11-29
FI942011A0 (en) 1994-04-29
ATE158181T1 (en) 1997-10-15
CA2120599A1 (en) 1993-05-13
AU712692B2 (en) 1999-11-11
HUT72964A (en) 1996-06-28
PT101019B (en) 1999-10-29
HU9401257D0 (en) 1994-08-29
JP3526864B2 (en) 2004-05-17
HU227531B1 (en) 2011-07-28
AU2895392A (en) 1993-06-07
JPH07506083A (en) 1995-07-06
PT101019A (en) 1994-02-28
GR3025237T3 (en) 1998-02-27
WO1993008795A1 (en) 1993-05-13
NO307644B1 (en) 2000-05-08
DE4210711A1 (en) 1993-05-06
DK0610357T3 (en) 1998-05-11
CA2120599C (en) 2003-04-15
EP0610357B1 (en) 1997-09-17

Similar Documents

Publication Publication Date Title
DK0610357T3 (en) Transdermal therapeutic systems with crystallization inhibitors
FI940427A0 (en) Transdermal therapeutic systems
ATE200028T1 (en) TRANSDERMAL DELIVERY DEVICE
MY109727A (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ITTO960469A0 (en) DEVICE FOR THE TRANSDERMAL ADMINISTRATION BY ELECTROTRANSPORT OF FENTANIL AND SUFENTANIL.
ATE209940T1 (en) IMPROVED TRANSDERMAL DEVICE WITH REDUCED DELAMINATION
DE69829961D1 (en) TRANSDERMAL DEVICE FOR THE ADMINISTRATION OF TESTOSTERONE
MX9804871A (en) TRANSDERMIC DEVICE FOR SUPPLY OF FLURBIPROFEN.
FI961282L (en) Transdermal therapeutic system containing acetylsalicylic acid as an active ingredient
ITTO960488A0 (en) DEVICE AND PROCEDURE FOR THE TRANSDERMAL ADMINISTRATION BY ELECTROTRANSPORT OF FENTANIL AND SUFENTANIL.
DK0650359T3 (en) Transdermal therapeutic system with the active substance 17-beta-estradiol (anhydrous)
DK0794770T3 (en) Transdermal preparation containing a loratidine metabolite with antihistamine action
DE59712215D1 (en) TRANSDERMALES THERAPEUTIC SYSTEM WITH A BISPHOSPHATE COMBINATION CONTAINING OSTRIOLS

Legal Events

Date Code Title Description
MK1K Patent expired